Showing results (111-120 of 141) with videos related to
Sort By:
Pageof 15
The Lancet. Gastroenterology & Hepatology|April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trialNadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.Journal of Inherited Metabolic Disease|September 17, 2019
Long-term outcome of methylmalonic aciduria after kidney, liver, or combined liver-kidney transplantation: The French experienceAnaïs Brassier, Pauline Krug, Florence Lacaille, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 11, 2022
Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)Cécile Cieuta-Walti, Aida Cuenca-Royo, Klaus Langohr, et al.Transplantation|May 5, 2023
Long-term Outcome of Asymptomatic Patients With Graft Fibrosis in Protocol Biopsies After Pediatric Liver TransplantationSteffen Hartleif, James Hodson, Carla Lloyd, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 18, 2020
Donor-targeted serotherapy as a rescue therapy for steroid-resistant acute GVHD after HLA-mismatched kidney transplantationJulien Zuber, Olivia Boyer, Bénédicte Neven, et al.Science Translational Medicine|September 21, 2022
Inverted direct allorecognition triggers early donor-specific antibody responses after transplantationXavier Charmetant, Chien-Chia Chen, Sarah Hamada, et al.Journal of Hepatology|March 2, 2010
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirinStefan Wirth, Carmen Ribes-Koninckx, Maria Angeles Calzado, et al.Digestive Diseases and Sciences|August 31, 2023
Multi-disciplinary Insights from the First European Forum on Visceral Myopathy 2022 MeetingFederica Viti, Roberto De Giorgio, Isabella Ceccherini, et al.The Lancet. Gastroenterology & Hepatology|July 5, 2022
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trialRichard J Thompson, Henrik Arnell, Reha Artan, et al.Journal of Hepatology|May 8, 2010
Differences in presentation and progression between severe FIC1 and BSEP deficienciesLudmila Pawlikowska, Sandra Strautnieks, Irena Jankowska, et al.Pageof 15